EC
Cardoso, Evelina
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study | Cancers |  | 2024 | 69 | 152 | ||
| Infant exposure to Fluvoxamine through placenta and human milk : a case series - A contribution from the ConcePTION project | Frontiers in psychiatry | | 2023 | 78 | 69 | ||
| Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study | Cancers | | 2023 | 171 | 89 | ||
| Interventions to Support Adherence to Oral Anticancer Therapies: Research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland | Supportive care in cancer | | 2022 | 291 | 214 | ||
| Population pharmacokinetics of palbociclib and its correlation with clinical efficacy and safety in patients with advanced breast cancer | Pharmaceutics | | 2022 | 128 | 155 | ||
| Optimizing oral targeted anticancer therapies study for patients with solid cancer: protocol for a randomized controlled medication adherence program along with systematic collection and modeling of pharmacokinetic and pharmacodynamic data | JMIR research protocols | | 2021 | 231 | 277 | ||
| Population pharmacokinetics of erlotinib in patients with non-small cell lung cancer: Its application for individualized dosing regimens in older patients | Clinical Therapeutics |  | 2020 | 371 | 1 | ||
| Therapeutic drug monitoring of targeted anticancer protein kinase inhibitors in routine clinical use: A critical review | Therapeutic Drug Monitoring | | 2020 | 256 | 1 | ||
| Optimization of the potential therapeutic benefit of protein kinase inhibitors used in cancer | | 2019 | 653 | 12 | |||
| Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry | Journal of Chromatography. B | | 2018 | 278 | 0 | ||
| Effect of adherence on pharmacokinetic/pharmacodynamic relationships of oral targeted anticancer drugs | Clinical Pharmacokinetics | | 2018 | 299 | 0 | ||
| Caractérisation du profil pharmacocinétique du saquinavir chez des patients HIV positifs | | 2012 | 338 | 9 |
